|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US6455677B1
(en)
|
1998-04-30 |
2002-09-24 |
Boehringer Ingelheim International Gmbh |
FAPα-specific antibody with improved producibility
|
|
US6465181B2
(en)
|
1999-03-25 |
2002-10-15 |
Abbott Laboratories |
Reagents and methods useful for detecting diseases of the prostate
|
|
JP2002543841A
(ja)
|
1999-05-17 |
2002-12-24 |
バイオファーム ゲゼルシャフト ツア バイオテクノロジシェン エントヴィックルング ウント ツム フェルトリーブ フォン ファルマカ エムベーハー |
ＴＧＦ−βスーパーファミリーの新規のメンバーであるＧＤＦ―１５の神経保護特性
|
|
AU2001288770A1
(en)
|
2000-09-08 |
2002-03-22 |
The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
|
|
SI2311873T1
(sl)
|
2004-01-07 |
2018-12-31 |
Novartis Vaccines And Diagnostics, Inc. |
M-CSF-specifična monoklonska protitelesa in njihova uporaba
|
|
EP2441466B1
(en)
|
2004-04-13 |
2014-07-23 |
St Vincent's Hospital Sydney Limited |
MIC-1 inhibiting agent
|
|
US20070128636A1
(en)
|
2005-12-05 |
2007-06-07 |
Baker Joffre B |
Predictors Of Patient Response To Treatment With EGFR Inhibitors
|
|
US20100278843A1
(en)
|
2007-08-16 |
2010-11-04 |
St. Vincent's Hospital Sydney Limited |
Agents and methods for modulating macrophage inhibitory cytokine (mic-1) activity
|
|
CN101896192A
(zh)
|
2007-10-09 |
2010-11-24 |
圣文森特医院悉尼有限公司 |
一种通过去除或灭活巨噬细胞抑制因子-1而治疗恶病质的方法
|
|
WO2009150255A2
(en)
|
2008-06-13 |
2009-12-17 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Markers for predicting response and survival in anti-egfr treated patients
|
|
NZ591484A
(en)
|
2008-09-29 |
2012-09-28 |
Roche Glycart Ag |
Antibodies against human il 17 and uses thereof
|
|
WO2010045495A2
(en)
|
2008-10-16 |
2010-04-22 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Fully human antibodies to high molecular weight-melanoma associated antigen and uses thereof
|
|
EP2209003A1
(en)
|
2009-01-16 |
2010-07-21 |
F. Hoffmann-Roche AG |
Means and methods for differentiating between fibrosis and cirrhosis
|
|
US7736861B1
(en)
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
|
US20120309697A1
(en)
|
2009-10-28 |
2012-12-06 |
Samuel Norbert Breit |
Methods of diagnosing and prognosing colonic polyps
|
|
US9212221B2
(en)
|
2010-03-03 |
2015-12-15 |
Detroit R & D, Inc. |
Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses
|
|
JP2013526852A
(ja)
|
2010-04-06 |
2013-06-27 |
カリス ライフ サイエンシズ ルクセンブルク ホールディングス |
疾患に対する循環バイオマーカー
|
|
EP2388594A1
(en)
|
2010-05-17 |
2011-11-23 |
Roche Diagnostics GmbH |
GDF-15 based means and methods for survival and recovery prediction in acute inflammation
|
|
TWI452136B
(zh)
|
2010-11-17 |
2014-09-11 |
中外製藥股份有限公司 |
A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation
|
|
EP2506015A1
(en)
|
2011-04-01 |
2012-10-03 |
Universität Regensburg |
A prognostic and therapeutic signature for malignant melanoma
|
|
EP2714738B1
(en)
|
2011-05-24 |
2018-10-10 |
Zyngenia, Inc. |
Multivalent and monovalent multispecific complexes and their uses
|
|
WO2013012648A1
(en)
|
2011-07-15 |
2013-01-24 |
Emory University |
Gdf15 in diagnostic and therapeutic applications
|
|
US8790651B2
(en)
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
CN102321173B
(zh)
|
2011-08-12 |
2013-04-03 |
中国医学科学院肿瘤研究所 |
人源化巨噬细胞抑制因子1单克隆抗体及其应用
|
|
EP2565262A1
(en)
|
2011-08-31 |
2013-03-06 |
VTU Holding GmbH |
Protein expression
|
|
EP3683228A3
(en)
|
2012-01-26 |
2020-07-29 |
Amgen Inc. |
Growth differentiation factor 15 (gdf-15) polypeptides
|
|
RS59045B1
(sr)
|
2012-09-26 |
2019-08-30 |
Univ Wuerzburg J Maximilians |
Monoklonalna antitela za faktor 15 rasta i diferencijacije (gdf-15)
|
|
ES2791183T3
(es)
|
2012-12-21 |
2020-11-03 |
Aveo Pharmaceuticals Inc |
Anticuerpos anti-GDF15
|
|
US11021752B2
(en)
|
2013-03-15 |
2021-06-01 |
Myriad Genetics, Inc. |
Genes and gene signatures for diagnosis and treatment of melanoma
|
|
AU2015206603B9
(en)
|
2014-01-14 |
2019-07-18 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for identification, assessment, prevention, and treatment of melanoma using PD-L1 isoforms
|
|
EP2899544B1
(en)
|
2014-01-28 |
2018-12-26 |
Roche Diagnostics GmbH |
Biomarkers for risk assessment and treatment monitoring in heart failure patients who receive B-type natriuretic peptide guided therapy
|
|
KR102410090B1
(ko)
|
2014-02-21 |
2022-06-16 |
넥타르 테라퓨틱스 (인디아) 프라이빗 리미티드 |
항-ｃｔｌａ－４ 항체 또는 항-ｐｄ－１ 항체와 조합한 ｉｌ－２ｒ베타-선택적 효현제
|
|
RS59700B1
(sr)
|
2014-03-26 |
2020-01-31 |
Univ Wuerzburg J Maximilians |
Monoklonalna antitela za faktor 15 (gdf-15) rasta i diferencijacije, i njihove upotrebe u lečenju kancerske kaheksije i kancera
|
|
PL3197493T3
(pl)
*
|
2014-09-25 |
2021-08-23 |
Aveo Pharmaceuticals Inc. |
Sposoby odwracania kacheksji i przedłużania przeżycia obejmujące podanie modulatora gdf15 i środka przeciwnowotworowego
|
|
EP3073268A1
(en)
|
2015-03-27 |
2016-09-28 |
Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts |
Biomarker panel for diagnosing cancer
|
|
CN108463246B
(zh)
|
2015-10-02 |
2025-02-28 |
尤利乌斯·马克西米利安维尔茨堡大学 |
使用人生长分化因子15(gdf-15)抑制剂和免疫检查点阻断剂的联合治疗
|
|
FI3356827T3
(fi)
|
2015-10-02 |
2024-01-03 |
Univ Wuerzburg J Maximilians |
GDF-15 diagnostisena markkerina immuunivasteen vapauttajilla annetun hoidon hoitovasteen ennustamiseksi
|
|
GB201517528D0
(en)
|
2015-10-02 |
2015-11-18 |
Julius Maximillians Universitãt Würzburg |
GDF-15 as a diagnosis marker for melanoma
|
|
SMT202500282T1
(it)
|
2015-11-18 |
2025-09-12 |
Bristol Myers Squibb Co |
Trattamento del cancro del polmone utilizzando una combinazione di un anticorpo anti-pd-1 e di un anticorpo anti-ctla-4
|
|
WO2017189724A1
(en)
*
|
2016-04-27 |
2017-11-02 |
Novartis Ag |
Antibodies against growth differentiation factor 15 and uses thereof
|
|
CN112912395B
(zh)
*
|
2018-08-20 |
2024-08-23 |
辉瑞公司 |
抗gdf15抗体、组合物和使用方法
|
|
US20230212274A1
(en)
|
2020-02-21 |
2023-07-06 |
The Children's Medical Center Corporation |
Method for treating asthma or allergic disease
|
|
CN114560938B
(zh)
|
2020-03-30 |
2023-05-23 |
中国人民解放军第四军医大学 |
抗gdf15中和性单克隆抗体及其应用
|
|
KR20230107309A
(ko)
|
2020-11-10 |
2023-07-14 |
카탈임 게엠베하 |
항-gdf15 항체 및 암 치료용 투여 용법
|